Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
60 Cards in this Set
- Front
- Back
The study of biological effects of chemicals |
Pharmacology |
|
A committee established to review and approve research involving human subjects |
institutional Review Board (IRB) |
|
Phase of clinical trials that involve healthy volunteers that do not have the medical condition |
Stage 1 |
|
What legal regulatory body identifies the standards for drugs related to safety, purity, packaging |
United States Pharmacopeia |
|
What legal regulatory body regulates the development and sale of drugs |
Food and Drug Administration (FDA) |
|
What legal regulatory body defines the nurse scope of practice, and is specific to each state |
Nurse Practice Act |
|
A medication is shown to have no effects on animals and has not been tested on humans |
Pregnancy Category B |
|
A substance that has high potential for abuse, the risk for severe dependence, and accepted medical use |
Schedule II |
|
The ability of a drug to only attack those systems in foreign cells |
Selective toxicity Good- antibiotics Poor-chemo |
|
This estimates the margin of safety of a medication |
Therapeutic index- Wide- safer- wider range of it being therapeutic Narrow- schedule, monitor with lab values to make sure they don't enter toxicity mode |
|
A high dose of a drug given rapidly to achieve effective connection is |
Loading dose- large dose given to jumpstart to get you therapeutic Maintenance dose- given regularly to continue therapeutic state |
|
What is the study of the absorption, distribution, metabolism, and excretion of a drug |
Pharmacokinetics Absorption-distribution-metabolism (liver)- excretion (kidneys) |
|
Routes of administration such as: intravenous, intramuscular, subcutaneous, Sublingual, rectal, topical, inhalation |
Parenteral (outside of GI tract)- altered by blood flow to the area, tissue type Enteral meds (through GI tract)- thru mouth or any GI tube Altered by GI motility, food in stomach, pH of stomach, amount of bowel surface area |
|
Occurs when the body forms antibodies to a particular drug causing an immune response when the person is re-exposed to the drug |
Drug Allergy Four main classifications 1) anaphylactic- airway- administer epinephrine 2) cytotoxic 3) serum sickness 4) delayed |
|
What is a decision making, problem solving process to provide efficient and effective care |
Nursing Process Five steps: assessment, nursing diagnosis, planning, implementation, evaluation |
|
What is the rest and digest piece of the ANS |
Parasympathetic nervous system/ Cholinergic |
|
What are the three neurotransmitters in the sympathetic system |
Dopamine, epinephrine, norepinephrine Epinephrine= cardiac dysrhythmia |
|
What is the main neurotransmitter of the parasympathetic nervous system |
Acetylcholine |
|
The parasympathetic nervous system has what effect on the bladder |
Bladder emptying |
|
Beta 2 medications are going to have an effect primarily on the |
Lungs |
|
Dopamine is used for more than one condition. How will you know what you are giving it for |
It is dose dependent Low dose- increase renal blood flow; protect the kidneys High dose- to control BP, works like epinephrine |
|
What medication can be used as a pre-op medication, an antispasmodic, and for bradycardia |
Atropine |
|
Epinephrine can be very potent. What are two side effects you can assess for |
Cardiac dysrhythmias and decreased urine output Alpha 1-blood vessels- increase blood pressure Beta 1-heart-increase heart rate Beta 2-bronchus- relax bronchioles |
|
What medication is available OTC that is similar to ephedrine |
Pseudoephedrine/ Sudafed |
|
What can you teach your patient to so about some of the unpleasant side effects from anticholinergic agents |
Dry mouth- hard candy, artificial saliva Constipation- fluid, fiber, stool softener |
|
When administering a beta blocker, prior to administration of this medication, what VS should you monitor |
HR and BP |
|
Nonselective adrenergic blocking agents, such as carvedilol (coreg), will have an effect on both |
Beta 1 and Beta 2 |
|
Clonidine, an alpha specific adrenergic agonist, can be used for the treatment of |
HTN, chronic pain, opiate withdrawal |
|
Sympathetic nervous system ___ heart rate |
Increases Parasympathetic nervous system decreases heart rate |
|
Chemicals that may have therapeutic value are tested on laboratory animals |
Preclinical Trials Purpose: To determine whether they have the effect on living tissue To evaluate adverse effects Chemicals discarded: Chemical does not have therapeutic activity Chemical is too toxic Chemical is highly teratogenic Safety margins are small |
|
Given to healthy volunteers: healthy young men- used to assess safety of the drug, determine the dose range and study the pharmacokinetics |
Phase I Dropped because: Not therapeutic in humans Cause unacceptable adverse effects Highly teratogenic Too toxic |
|
Clinical trials performed at various places (hospitals, clinics, doctor offices) on individuals who have the disease |
Phase II Dropped because: Less effective than anticipated Too toxic Produces unacceptable adverse effects Low benefit to risk ratio Not more effective than another drug |
|
Trial where drug is used over a large clinical market and monitored closely by prescribers |
Phase III After phase is completed: Application is submitted to the FDA for approval Drug is given brand (trade) name |
|
Phase of continual evaluation after a drug is approved and is available to all |
Phase IV FDA continues to monitor and evaluate any unexpected adverse effects |
|
Pregnancy category where no controlled studies have been conducted in humans but animal studies show no risk to the fetus |
Category B |
|
Pregnancy category where no controlled studies have been conducted in humans or animals |
Category C |
|
Pregnancy category where controlled studies in humans show no risk to the fetus |
Category A |
|
Pregnancy category where controlled studies in both animals and humans demonstrate fetal abnormalities and the risk in pregnant women outweighs any possible benefit |
Category X |
|
Pregnancy category where evidence of human risk to the fetus exists, however benefits may outweigh risks in certain situations |
Category D |
|
Controlled substance that has a low potential for abuse relative to substances in C-III |
C-IV |
|
Controlled substance in which substances have a high potential for abuse, which may lead to severe psychological or physical dependence, and have a currently accepted medical use (with severe restrictions) |
C-II |
|
Controlled substance that have a low potential for abuse relative to substances listed in C-IV and consist primarily of preparations containing limited quantities of certain narcotics |
C-V |
|
Controlled substances that have a high potential for abuse, have no currently accepted medical use in treatment in the US and have a lack of accepted safety for use under medical supervision |
C-I |
|
Controlled substance that have less potential for abuse than substances in C-I or C-II and abuse may lead to moderate or low physical dependence or high psychological dependence |
C-III |
|
Treatment of heart failure |
Dobutamine (sympathomimetic) |
|
Treatment of shock |
Dopamine (sympathomimetic) Given in emergent situations when perfusion is decreased Dose dependent: low=increase renal blood flow (kidneys) High=control blood pressure (acts like epinephrine) |
|
Treatment of hypotension |
Ephedrine (sympathomimetic) Used in hypotension and mild forms of asthma Constricts blood vessels and is also used as cold/allergy meds |
|
Treatment of shock, bronchospasms, to prolong effects of local anaesthetics |
Epinephrine Anaphylaxis, cardiac arrest, bronchospasms, shock High doses can lead to cardiac dysrhythmia Expected side effect: pallor (all blood shunted to vital organs) |
|
Treatment of shock, used during cardiac arrest |
Norepinephrine |
|
Treatment of HTN, chronic pain, ease opiate withdrawal |
Clonidine Stimulates Alpha 2 to vasodilate Alpha specific adrenergic agonist |
|
Treatment of orthostatic hypotension |
Midodrine Stimulates Alpha 1 Alpha specific adrenergic agonist |
|
Treatment of shock like states, tachycardia, glaucoma, cold and allergies, rhinitis, otitis media |
Phenylephrine Stimulates Alpha 1 to vasoconstrict Alpha specific adrenergic agonist |
|
Treatment and prevention of bronchospasm (PO or inhalation) |
Albuterol (Proventil) Beta specific adrenergic agonist Selective for beta 2 receptors |
|
Treatment and prevention of bronchial asthma and reversible bronchospasms (nebulizer) |
Levalbuterol (Xoponex) Beta specific adrenergic agonist Specific for beta 2 receptors |
|
Treatment of life threatening ventricular arrhythmias |
Amiodarone Nonselective adrenergic blocking agent |
|
Treatment of HTN and HF |
Carvedilol (Coreg) Nonselective adrenergic blocking agent |
|
Treatment of HTN, clonidine withdrawl |
Labetalol Nonselective adrenergic blocking agent |
|
Alpha 1 selective adrenergic blocking agents |
Doxazoain (Cardura) and Tamsulosin (Flomax) Stimulates vasodilation to decrease BP, decrease prostate and bladder contractions Used to treat HTN and BPH Side effects: cardiac dysrhythmia, flushing, hypotension, reflex tachycardia |
|
Nonselective beta adrenergic blocking agent |
Propranolol (Inderal) Used to treat HTN, heart rhythm, and stage fright |
|
Beta 1 selective adrenergic blocking agent |
Atenolol (Tenormin) and Metoprolol (Lopressor) Used to treat HTN, heart rhythm, heart rate, and chronic angina Also good to use with patients who have a history of an airway diagnosis- they do not block the beta 2 receptor site therefore they do not block the sympathetic bronchodilation |